Ertapenem
Back to searchMolecule Structure
Scientific Name
Ertapenem
Description of the Drug
Ertapenem is a carbapenem antibiotic used for the treatment of moderate to severe infections caused by susceptible bacteria.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00303
http://www.drugbank.ca/drugs/DB00303
Brand Name(s)
Not Available
Company Owner(s)
Gland Pharma Ltd, Eugia Pharma Specialities Ltd, Savior Lifetec Corp, Acs Dobfar Spa, Merck Sharp And Dohme Llc A Sub Of Merck And Co Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34454 | ||
| PharmGKB | PA164777032 | ||
| Human Metabolome Database | HMDB0014448 | ||
| DrugBank | DB00303 | ||
| PubChem: Thomson Pharma | 14761086 | 14785384 | |
| PubChem | 150610 | ||
| Nikkaji | J2.766.498I | ||
| EPA CompTox Dashboard | DTXSID50165456 | ||
| DrugCentral | 1046 | ||
| Brenda | 3762 | ||
| ChemicalBook | CB0722982 | ||
| Guide to Pharmacology | 10906 | ||
| rxnorm | ERTAPENEM SODIUM | ERTAPENEM | INVANZ |
| ChEBI | 404903 | ||
| ZINC | ZINC000003918453 |
